Skip to content
Neuronet
Neuronet - The support action for EU research on neurodegeneration
  • ABOUT
        • Objectives
        • Glossary
        • Work Packages
        • Partners
        • Executive Committee
        • Task Forces
        • Working Groups
        • Scientific Coordination Board
  • EVENTS
        • 2021: Virtual event
        • 2020: Virtual Event
        • 2019: The Hague
        • Event Calendar
  • NEWS
        • Latest news
        • Neuronet newsletters
        • Neuronet in the Media
  • PROJECTS
        • Ongoing Projects
        • Completed Projects
        • Project Overview
        • Project Timescales
  • RESOURCES
        • Asset Map
        • Project Tools
        • Regulatory & HTA Decision Tool
        • Neuronet Tools
        • Neuronet Deliverables
        • Neuronet Presentations
        • Publications
        • Useful resources for young researchers
  • KNOWLEDGE BASE

Sin categoría

Spotlight on early-career investigators: a Neuronet interview with Clint Hansen

10th September 20212nd November 2020
Neuronet Early careers investigator interview: Clint Hansen group leader of Neurogeriatrics Kiel at Kiel University Mobilise-d project 800x535

In this interview, we talk to Dr. Clint Hansen, who is deputy group leader of

Showcasing IMI projects: Neuronet at #30AEC

4th November 202027th October 2020

Neuronet has been designed to boost synergy and collaboration across the projects of the Innovative

PD-MitoQUANT researchers organise online public meeting series

4th November 202023rd October 2020
PD-Mitoquant online series

PD-MitoQUANT researchers at the Royal College of Surgeons in Ireland are organising an online public

VUmc is recruiting a senior researcher / data manager for the AMYPAD project

4th November 202023rd October 2020
Job opportunity

Vumc is seeking a Senior Researcher / Data Manager to join its team in Amsterdam.

Mobilise-D releases a new video explaining its clinical trials

19th November 20209th October 2020
Mobilise-D releases a new video explaining its clinical trials

The Mobilise-D project has released a new video about the Mobilise-D Clinical Study! Being able

First RADAR-AD participant completes 2 month participation in RADAR-AD study

12th November 20207th October 2020
First RADAR-AD participant completes 2 month participation in RADAR-AD study

The first participant enrolled in the main RADAR-AD study has completed the two-month assessment period

The ADAPTED project came to a close on 30th September

4th November 20205th October 2020
ADAPTED project logo

The ADAPTED project came to a close on 30th September. After four years of hard

Neuronet convenes 5th meeting of its Scientific Coordination Board

17th August 20221st October 2020
Neuronet Scientific Coordination Board Meeting Madrid January 2020, From left to right, Martin Hoffmann-Apitius, Mercè Boada, Jean Georges, Manuela Rinaldi, Andreas Ebneth, Nina Coll, Jochen Prehn, Hugh Marston, Carlos Diaz, Craig Ritchie, Sandra Pla, Christophe Bintener, Lennert Steukers

Our Scientific Coordination Board (also known as the SCB) plays a central role in determining

Fifth Neuronet newsletter issue launched

14th January 202230th September 2020
Neuronet logo - The support action for EU research on neurodegeneration holds meeting on key assets

Welcome to the fifth issue of the Neuronet newsletter! We hope this newsletter finds you

Neuronet receives positive feedback from its mid-term review

4th November 202025th September 2020
The Neuronet consortium meeting participants from left to right; Esteban di Falco, Arthur Roach, Carlos Díaz (Project Coordinator), Hugh Marston, Christophe Bintener, Philippe Rocolle, Nina Coll, Jean Georges, Darrel Pemberton (Project Leader), Elisabetta Vaudano (Innovative Medicines Initiative), Sandra Pla, Jacoline Bouvy, Rakesh Kantaria, Manuela Rinaldi, Giovanni Esposito (European Brain Council, representing EBRA – European Brain Research Area)

Earlier this summer, Neuronet underwent a thorough mid-term review at the Innovative Medicines Initiative (IMI). 

Post navigation
Older posts
Newer posts
← Previous Page1 … Page17 Page18 Page19 … Page29 Next →

LATEST NEWS

  • Neuronet publishes Frontiers in Neurology article, analysing the structure, assets and collaborative networks in the IMI neurodegeneration portfolio

    9th November 2022
    The Innovative Medicines Initiative (IMI) was launched in 2008, with an initial budget of €8bn.Read More
  • Spotlight on Early-Career researchers a Neuronet interview with Ilja Saris

    5th September 2022
    In this Neuronet spotlight on early-career researcher interview, we speak with Ilja Saris who worksRead More
  • Spotlight on Communication experts: A Neuronet Blog with Cindy Birck

    29th August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More
  • Webinar series: Mobilise-D presents its four patient cohorts

    25th August 2022
    Mobilise-D starts the autumn webinar series presenting the needs, technologies, protocols and user perspectives forRead More
  • Spotlight on Communication experts: A Neuronet Blog with Yoanna de Geus

    23rd August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More

Neuronet

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 821513. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Parkinson’s UK.

Any information on this website solely reflects the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.

 

 

Innovative Medicines InitiativeEU Flag logoEuropean Federation of Pharmaceutical Industries and Associations logoParksinson's UK logo

Disclaimer
About IMI
Legal notice
Privacy policy

@ 2019 – IMI-NEURONET

© 2026 - IMI-NEURONET
We use cookies to offer you a better browsing experience and to analyze site traffic. Read about how we use cookies and how you can control them in our Cookie Policy. If you continue to use this site, you consent to our use of cookies. AcceptCookie policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT